Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × OTHER × Hepatitis × Clear all

Phase

Phase NA 3 Phase 2 1 Phase 1/2 1

Status

Sponsor Class

INDUSTRY 2 OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 1655 Carcinoma, Non-Small-Cell Lung 1168 Prostatic Neoplasms 883 Colorectal Neoplasms 742 Multiple Myeloma 645 Leukemia, Myeloid, Acute 622 Lung Neoplasms 602 Neoplasms 598 Neoplasm Metastasis 560 Lymphoma 505 Pancreatic Neoplasms 499 Carcinoma, Hepatocellular 493 Stomach Neoplasms 462 Leukemia 450 Recurrence 436 Melanoma 395 Leukemia, Lymphocytic, Chronic, B-Cell 394 Precursor Cell Lymphoblastic Leukemia-Lymphoma 384 Lymphoma, Non-Hodgkin 381 Ovarian Neoplasms 379 Myelodysplastic Syndromes 364 Squamous Cell Carcinoma of Head and Neck 363 Lymphoma, Large B-Cell, Diffuse 362 Brain Neoplasms 360 Head and Neck Neoplasms 354 Rectal Neoplasms 341 Glioblastoma 337 Carcinoma, Renal Cell 301 Hodgkin Disease 296 Esophageal Neoplasms 294

Interventions

Ursodeoxycholic Acid 1 Steroids 1 Prednisone 1 Mycophenolic Acid 1 Methylprednisolone Hemisuccinate 1 Methylprednisolone 1 Adrenal Cortex Hormones 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04810156 2022-12-14

I-HEP

Herlev Hospital

Phase 2 Unknown

Hepatitis, Neoplasms, Chemical and Drug Induced Liver Injury

Data powered by HemOnc (CC BY 4.0) Colophon ⚡